Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Washington Companies Raised $84.9M in September—But Mostly in One Deal
|
Gregory T. Huang |
10/08/09 |
Seattle
|
|
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub
|
Carl Weissman |
10/01/09 |
Seattle
|
|
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/25/09 |
Seattle
|
|
Free & Clear Acquired for $100M-Plus, Calypso Gets $50M, Ensequence Ensnares $20M, & More Seattle-Area Deals News
|
Gregory T. Huang |
09/22/09 |
Seattle
|
|
Lee Hood’s New Idea, Integrative Diagnostics for Early Cancer Detection, Raises $7.5M
|
Luke Timmerman |
09/21/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say
|
Luke Timmerman |
08/26/09 |
Seattle
|
|
Can The Genome Be Cracked for $5,000? OVP, Enterprise Partners Say Yes in $45M Round
|
Luke Timmerman |
08/24/09 |
National
|
|
Covance Buys Key Piece of Merck’s Rosetta Operation in Seattle
|
Luke Timmerman |
07/29/09 |
Seattle
|
|
Clarus Leans on Customer Reviews at the Broad Institute to Bet on NanoString
|
Luke Timmerman |
07/29/09 |
Boston
|
|
NanoString Nabs $30M in Third Venture Round (Which It Hopes Will Be The Last)
|
Luke Timmerman |
06/09/09 |
Seattle
|
|
Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/28/09 |
Seattle
|
|
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use
|
Luke Timmerman |
05/27/09 |
Seattle
|
|
The $1,000 Genome is Coming: How Will It Change the World?
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Accelerator’s New Startup, Xori, Aims to Use Chicken Cells to Make Better Antibody Drugs
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/26/09 |
Seattle
|
|
Nanostring CEO Perry Fell Departs
|
Luke Timmerman |
03/24/09 |
Seattle
|
|
Leroy Hood, ISB Scientists Spot Genes For “Mad Cow” Disease; May Lead to Diagnostic Test
|
Luke Timmerman |
03/24/09 |
Seattle
|
|
Harnessing the Crowd to Make Better Drugs: Merck’s Friend Nails Down $5M to Propel New Open Source Era
|
Luke Timmerman |
03/02/09 |
Seattle
|
|
Cell Therapeutics Nears Brink, ‘Hutch’ Dog Breed Test Hits Market, Lee Hood’s Institute Grows & More Seattle Area Life Sciences News
|
Luke Timmerman |
02/19/09 |
Seattle
|
|
What Breed is Your Dog? Geneticists From the “Hutch” Pioneered New Test to Provide Answer
|
Luke Timmerman |
02/18/09 |
Seattle
|
|
Leroy Hood’s Institute Gains Momentum, Nine Years After Starting with “Crazy” Idea
|
Luke Timmerman |
02/13/09 |
Seattle
|
|
Hey, Don’t Forget the Puget Sound Life Sciences Universe!
|
Luke Timmerman |
02/09/09 |
Seattle
|
|
Sticking it to the VC Man: Johnny Stine Builds Biotech Startup on a Shoestring
|
Luke Timmerman |
02/06/09 |
Seattle
|
|
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked)
|
Gregory T. Huang |
12/31/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
